(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
The ultimate goal of our research is to understand the mechanisms that determine organ size through selection of progenitor cells. Proper determination of organ size is crucial for normal organ form and function, and specification of organ progenitors seems to depend on a balance of inductive and restrictive signals. We currently understand much less about the signals that limit cardiac progenitor specification compared to the signals that promote cardiac progenitor formation. Therefore, our studies are focused on the signals that restrict the size of the cardiac progenitor field.
Wild-type (WT) zebrafish heart (left). Enlarged heart (right) with more cells. Hearts are from 2-day-old embryos. Red is ventricle. Green is atrium.
Inhibiting RA signaling leads to increased cardiac specification. In situ hybridizations for cmlc2, an early cardiac marker. Wild-type embryos (left). Embryo where RA signaling (right) has been inhibited.
Inhibition of hoxb5b function leads to an increase in atrium cell number. Heart from wild-type embryo (left). Heart from embryo where hoxb5b function (right) was inhibited and atrium has more cells. Hearts are from 2-day-old embryos. Red is ventricle. Green is atrium.
We are interested in understanding the mechanisms by which different signaling pathways restrict cardiomyocyte formation. One of the few pathways that has been shown to restrict the size of the heart is retinoic acid (RA) signaling. Inhibition of RA signaling leads to the specification of more cardiomyocytes in vertebrates. We are investigating what genes downstream of RA signaling are involved in restricting the number of cells in the heart and are exploring the mechanisms by which novel mutations affect RA signaling’s ability to restrict cardiac cell number.
We are interested in understanding what determines the fates of cells in individual heart chambers. Our research revealed that hoxb5b is required to specifically restrict the number of atrial cells. This suggests that there are factors that may determine individual chamber identity. We seek to understand the mechanisms downstream of hoxb5b that restrict atrial cell number, characterizing a novel mutant that may specifically affect atrial size and identifying factors that restrict ventricular cell number.
Learn about our lab’s work with zebrafish as the model organism for our research and about opportunities in our lab to gain experience with this versatile animal model.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2016 Cincinnati Children's Hospital Medical Center